Ropes & Gray LLP has advised Nuvalent, Inc. Davis Polk & Wardwell LLP and Slaughter and May have advised GSK plc. Sidley Austin LLP has represented...
GSK to Acquire Nuvalent in $10.6 Billion Oncology Deal
Shionogi Increases Stake in ViiV Healthcare Through $2.125 Billion Transaction with GSK and Pfizer
Wachtell, Lipton, Rosen & Katz has advised Pfizer. Skadden has advised Shionogi. Slaughter and May has advised GSK plc. GSK plc and Shionogi & Co., Ltd...
GSK Acquires Worldwide License for Empirico’s COPD Candidate EMP-012
Wilson Sonsini Goodrich & Rosati has advised Empirico, and Davis Polk & Wardwell has advised GSK. GSK plc and Empirico Inc. have entered into a worldwide...
GSK’s Acquisition of Efimosfermin
Cleary Gottlieb Steen & Hamilton represented GSK, while Sullivan & Cromwell represented Boston Pharmaceuticals in the transaction. GSK announced its acquisition of Boston Pharmaceuticals’ lead asset...
ABL Bio’s Worldwide Licensing Agreement with GSK
Wilson Sonsini Goodrich & Rosati advised ABL Bio on the transaction. Simmons & Simmons has advised GSK. ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company...
Muna Therapeutics’ Research Alliance with GSK
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Muna Therapeutics in the transaction. Muna Therapeutics, a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases,...
GSK’s Acquisition of CMG1A46 from Chimagen Biosciences
Appleby acted as Cayman Islands counsel to GSK Plc on the deal. GSK proposed the acquisition of full global rights to CMG1A46, a clinical-stage dual CD19...
GSK’s Acquisition of Aiolos
Cleary Gottlieb Steen & Hamilton is representing GSK plc in the transaction. SK plc (GSK) entered into an agreement on January 8, 2024 to acquire Aiolos Bio,...
GSK’s Licensing Agreement with Hansoh Pharma for HS-20093
Davis Polk & Wardwell advised GSK on the transaction. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
GSK’s Licensing Agreement with Hansoh Pharma
Davis Polk & Wardwell advised GSK on the deal. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
23andMe’s New Data Licensing Agreement with GSK
Davis Polk & Wardwell advised GSK on the deal. 23andMe Holding Co. (Nasdaq: ME) (“23andMe”) announced a new non-exclusive data license with GSK plc (LSE/NYSE: GSK) which...
GSK and Pfizer’s Demerger of Haleon
Wachtell, Lipton, Rosen & Katz and Clifford Chance served as Pfizer’s legal advisors, and Skadden, Arps, Slate, Meagher & Flom served as its tax advisor for...